Evidence map›Paper›PMID 21947122›Full record

ReviewNature reviews. Nephrology2011

The mechanism of hypocalciuria with NaCl cotransporter inhibition.

Robert F Reilly, Chou-Long Huang

Abstract readReview
PubMed Publisher
In one paragraph

Review in Nature reviews. Nephrology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed, 1 pooled it
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 1 synthesis or guideline pooled it, 64 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Review
  5. Osteoporotic fracture risks of thiazides and dihydropyridines in angiotensin modulator users.Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2025
    Article
  6. Review
  7. Renal Hypokalemia: An Endocrine Perspective.The Journal of clinical endocrinology and metabolism · 2024
    Review
  8. Article
  9. Review
  10. Breaking the Cycle of Recurrent Calcium Stone Disease.Advances in kidney disease and health · 2023
    Review
  11. Article
  12. Observational
  13. Renal calcium and magnesium handling in Gitelman syndrome.American journal of translational research · 2022
    Review
  14. A novel mutation ofSAGE open medical case reports · 2022
    Article
  15. Three Novel Homozygous Mutations of theInternational journal of general medicine · 2021
    Article
  16. Review
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Robert F ReillyDepartment of Medicine, VA North Texas Health Care System, The University of Texas Southwestern Medical Center at Dallas, 4500 South Lancaster Road, Dallas, TX 75390-8856, USA. robert.reilly2@va.gov
Chou-Long Huang
The University of Texas Southwestern Medical Center · USVA North Texas Health Care System · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Thiazide diuretics are used to prevent the recurrence of calcium-containing kidney stones. The ability of these drugs to reduce urinary calcium excretion has a key role in this process. Although studies have shown a reduction in the recurrence rate of calcium-containing stones in patients treated with thiazides, whether hypocalciuria results from increased calcium reabsorption in the proximal or distal nephron is still unclear. When extracellular fluid volume is considerably reduced, the proximal tubule is likely to have a major role in thiazide-induced hypocalciuria. This process frequently occurs when high doses of thiazides and sodium restriction are prescribed for the treatment of kidney stone disease. The distal tubule is predominantly involved in NaCl cotransporter inhibition-induced hypocalciuria when the extracellular fluid volume is not reduced, a clinical scenario observed in patients with Gitelman syndrome. In this Perspectives article, we discuss the evidence supporting the hypocalciuric effects of NaCl cotransporter inhibition in the proximal and distal nephron.

Indexed as

AnimalsCalciumCalcium Metabolism DisordersDiet, Sodium-RestrictedDisease Models, AnimalGitelman SyndromeHumansKidney CalculiKidney Tubules, DistalKidney Tubules, ProximalMiceMice, KnockoutSodium Chloride Symporter InhibitorsSodium-Potassium-Chloride SymportersCalciumSodium Chloride Symporter InhibitorsSodium-Potassium-Chloride Symporters

Identifiers

PMID21947122
OpenAlexW2079653547

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.